|
Breast Disease
ISSN: 0888-6008 Volume 31-32; 4 issues Institutional subscription (print and online) for 2010: €418 / US$544 (including postage and handling) Click on the subscribe button for more options, including personal subscription prices. Status Report: Last issue (volume 30) online on 12 October 2009 Next issue (volume 31) scheduled for January 2010 Aims and Scope Editorial Board Submission of Manuscripts Abstracted in Download flyer for this journal |
|
||||||||||||||
|
Editor-in-Chief Jeffrey E. Green
Chief, Transgenic Oncogenesis and Genomics Section Laboratory Cancer Biology and Genetics National Cancer Institute Building 37, Room 4054 37 Convent Dr. MD 20892 Bethesda USA E-mail: jegreen@nih.gov Founding Editor Edison T. Liu
Executive Director, Genome Institute of Singapore Editorial Board
See instructions to authors. The recent expansion of work in the field of breast cancer inevitably will hasten discoveries that will have impact on patient outcome. The breadth of this research that spans basic science, clinical medicine, epidemiology, and public policy poses difficulties for investigators. Not only is it necessary to be facile in comprehending ideas from many disciplines, but also important to understand the public implications of these discoveries. Breast Disease publishes review issues devoted to an in-depth analysis of the scientific and public implications of recent research on a specific problem in breast cancer. Thus, the reviews will not only discuss recent discoveries but will also reflect on their impact in breast cancer research or clinical management. From 2009 onward, Breast Disease also started publishing unsollicited peer-reviewed articles. The topics can cover basic cellular and molecular biology, epidemiology, genetics, clinical research, imaging, and social and legal issues. The editorial team believes that Breast Disease will be a timely and important addition to the information needs of scientists, clinicians and policy makers. Abstracted in
EBSCO database,
Pubmed,
PubsHub,
Scopus
Backvolumes
11-30
Conferences
|
|||||||||||||||